×
Back to Agenda
Generative Artificial Intelligence in Regulatory Affairs: A Journey of Industry Implementation
Session Chair(s)
Paul Bolot, PharmD, MSc
Global Regulatory Strategist
Bayer Consumer Care AG, Switzerland
Explore the transformative potential of generative AI (genAI) in Regulatory Affairs. This session will share insights and experiences from industry, focusing on education, culture change, and impactful use cases.
Learning Objective : Recognize the value and potential of generative Artificial Intelligence (genAI) in Regulatory Affairs (RA); Outline how use cases are selected and implemented by Industry in their RA departments; Identify examples of application of genAI in RA; Discuss how to adapt and practice genAI within your own RA organization.
Speaker(s)
BMS Experience
Sandra Krogulski, MA
Bristol Myers Squibb, United States
Director, GRSO Innovation and Business Operations Lead
J&J Experience
Joseph Markmann
Johnson&Johnson, United States
Principal Data Science Lead, Global Regulatory Affairs
Introduction to genAI
Ben Moscovitch, MA, MBA
Amazon Web Services, United States
Public Policy
Novartis Experience
David Yao, PharmD
Novartis, United States
Associate Director, Regulatory Affairs CMC
Have an account?